lindas have a posse
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Buy now or cry later!
DCVax has a very high QLAY benefit for older patients especially considering the compassionate use data released by Bosch on 3/15/2023. Orphan and rare diseases have a threshold of 100K per QLAY but DCVax will be well under that limit. DCVax will be approved by MHRA and NICE this year.
All my opinion based upon published regulatory criteria.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169141878
Buy now or cry later!
Optune, junk science!
I agree amazing opportunity that nobody's going to gaslight us into questioning!
The trial was not "cash burn" but required R&D INVESTMENT!
That's right Roman!
100B market cap!
Virtu CEO says he didn't spoof NWBO stock.
We didn’t spoof this company or any other company. Not what a MM does. I also just checked and we are long GME and short an immaterial amount of AMC. That will all change at 9:31. That’s what MMs do. These bullsh*t narratives are pushed by grifters to take advantage of you.
— Doug Cifu (@Dougielarge) March 23, 2023
Very sorry for your loss.
An 8:29 AM PR wouldn't have gotten us on CNBC, CNN, or other big news. We are in a risk off market. Nobody buying OTC stocks. That will change once we get a short squeeze and uplist on RA approval.
This is an absurd narrative. My broker TD Ameritrade sent me the PR alert the evening MHRA issued the MIA. Anyone who's an NWBO investor was made aware of this very material event. It doesn't matter what time the alert went out. If investors don't read their emails or push notifications that's not the fault of management. We all knew MHRA approved MIA before the market opened today. Nobody got front runned with this completely professional news release. We had a very healthy 10% gain today. Yet everyone wants to complain about something.
As always well said for good measure!
TD Ameritrade sent me the PR last night before Dave Innes!!!!
TD Ameritrade - Securities Alert
Delivered by Markit On Demand
Mon Mar 20 2023 7:47:15 PM EDT
Log On to your TD Ameritrade Account:
https://invest.ameritrade.com/grid/p/login
BusinessWire, GlobeNewswire and PR Newswire News
============================================================
Northwest Biotherapeutics Inc NWBO:OTCQB
Northwest Biotherapeutics and Advent BioServices Announce
Receipt of License for Commercial Manufacturing at Sawston,
U.K.
Facility
We are in a risk off market. I am happy with todays progress. 10% gains are great for an OTC prerevenue biotech firm.
None of this matters, really.
Swing traders want the stock to retrace so they can ride it up again
PR timing doesn't matter. Revenue!
Derisked, derisked, derisked!
Trillion dollar technology.
Yes things take longer than expected but the results are only positive.
Very true. The MIA wouldn't be issued for a biologic which MHRA would not approve. The PIP would not have occurred if DCVax wasn't able to be approved. Our problem isn't the immense progress made by this world-class management team.
Rather we're in the middle of a risk off market event where very few are willing to speculate on biotech especially one that's prerevenue trading on OTC and manipulated daily. I believe that will change once we get institutional partners.
Landmark Trial Data!
JAMA!
MHRA Approved Manufacturing!
MHRA Trial Endorsement (PIP)!
Global Patent Protection!
Global Approval Imminent!
Trillion dollar technology!
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
https://www.researchsquare.com/article/rs-2591941/v1
https://nwbio.com/glioblastoma-drug-development-summit/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169815671
Thank you
Savannah would be wonderful.
Maybe they can't issue guidance on MAA because they're in process with ILAP?
Did the first pioneers know how long it would take to reach California from St Louis when first departing on the Oregon Trail? Linda Powers cannot provide guidance on when regulators will approve DCVax.
Yes, tens of billions in revenue seems lacking.
Trillion dollar technology!
Time to celebrate
I am never wrong. Regulators and journal editors take longer than I predict.
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-and-advent-bioservices-announce-receipt-of-license-for-commercial-manufacturing-at-sawston-uk-facility-301776725.html
I did this like over a year ago. I am celebrating now. Have a good evening.
Sorry, you don't know NYSE rules. The 90 day period does not apply. I already went through this with Poorman like a year ago.
It's billions then trillions. Sorry you can't keep up. Science is hard.
NYSE allows immediate uplist for companies previously listed on another exchange.
Once we get above $4 we can have an instant uplist to NYSE which I suspect Linda Powers will do as soon as it's possible. The question really happens to be which firm will be our DMM? Not GTS or Citadel ;)
Billion and billions in market cap headed our way.
Trillion dollar technology!
Time to pop a bottle!
Congratulations Linda Powers and the entire Northwest Biotherapeutics team!
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
https://www.researchsquare.com/article/rs-2591941/v1
https://nwbio.com/glioblastoma-drug-development-summit/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169815671
HappyLibrarian, Jerry Campbell, and other moderators.
Will you please pin the revelatory GBM presentation Marnix Bosch gave on 3/15/2023?
https://nwbio.com/glioblastoma-drug-development-summit/
At this event Northwest Biotherapeutics' CTO reiterated that DCVax may be the platform for treating all solid tumors. We also learned that rGBM patients can have additional resections upon tumor reoccurrence from which subsequent batches of vaccine are made prolonging patient survival even further than the Landmark PIII Trial. I hope you will consider helping make all readers on this forum aware of these extremely significant updates!
Thank you,
COl